- Report
- August 2024
- 84 Pages
Egypt
From €3420EUR$3,500USD£2,855GBP
- Report
- October 2023
- 172 Pages
Global
From €4397EUR$4,500USD£3,671GBP
- Report
- October 2023
- 189 Pages
Global
From €4397EUR$4,500USD£3,671GBP
- Report
- October 2023
- 140 Pages
Global
From €2930EUR$2,999USD£2,446GBP
- Report
- April 2023
- 147 Pages
Global
From €5861EUR$5,999USD£4,893GBP
- Report
- July 2022
- 225 Pages
Global
From €3517EUR$3,600USD£2,936GBP
- Report
- May 2022
- 80 Pages
Asia Pacific
From €1466EUR$1,500USD£1,224GBP
- Report
- May 2022
- 80 Pages
Europe
From €1466EUR$1,500USD£1,224GBP
- Report
- September 2024
- 105 Pages
Greece
From €2675EUR$2,933USD£2,311GBP
- Report
- September 2024
- 100 Pages
Argentina
From €2675EUR$2,933USD£2,311GBP
- Report
- September 2024
- 118 Pages
Italy
From €2675EUR$2,933USD£2,311GBP
- Report
- September 2024
- 26 Pages
Italy
From €995EUR$1,091USD£860GBP
- Report
- September 2024
- 28 Pages
United Kingdom
From €995EUR$1,091USD£860GBP
- Report
- September 2024
- 128 Pages
France
From €2675EUR$2,933USD£2,311GBP
- Report
- September 2021
- 119 Pages
Russia
From €2200EUR$2,412USD£1,901GBP
- Report
- August 2024
- 223 Pages
China
From €3908EUR$4,000USD£3,263GBP
- Report
- February 2024
- 90 Pages
Global
From €3500EUR$3,837USD£3,024GBP
- Report
- May 2022
- 99 Pages
Global
From €3500EUR$3,837USD£3,024GBP
- Report
- October 2023
- 94 Pages
Global
From €3500EUR$3,837USD£3,024GBP
- Report
- October 2024
- 22 Pages
Romania
From €995EUR$1,091USD£860GBP
The Ibuprofen market is a segment of the Over the Counter (OTC) Drugs industry. Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used to treat pain, fever, and inflammation. It is available in a variety of forms, including tablets, capsules, gels, creams, and liquids. Ibuprofen is one of the most widely used OTC drugs, and is available in both generic and branded forms. It is often used to treat mild to moderate pain, as well as inflammation associated with arthritis and other conditions. Ibuprofen is also used to reduce fever and to treat menstrual cramps.
The Ibuprofen market is highly competitive, with a number of major players. Some of the leading companies in the market include Johnson & Johnson, Bayer, Pfizer, GlaxoSmithKline, and Novartis. Show Less Read more